136 related articles for article (PubMed ID: 16245280)
1. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
2. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
Ozerdem U; Stallcup WB
Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
[TBL] [Abstract][Full Text] [Related]
3. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
Ozerdem U
Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
[TBL] [Abstract][Full Text] [Related]
4. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Welén K; Jennbacken K; Tesan T; Damber JE
Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
[TBL] [Abstract][Full Text] [Related]
5. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
6. Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.
Shen H; Schuster R; Lu B; Waltz SE; Lentsch AB
Prostate; 2006 Dec; 66(16):1721-8. PubMed ID: 16941672
[TBL] [Abstract][Full Text] [Related]
7. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M
Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689
[TBL] [Abstract][Full Text] [Related]
8. Targeting neovascular pericytes in neurofibromatosis type 1.
Ozerdem U
Angiogenesis; 2004; 7(4):307-11. PubMed ID: 15886874
[TBL] [Abstract][Full Text] [Related]
9. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
Ozerdem U; Grako KA; Dahlin-Huppe K; Monosov E; Stallcup WB
Dev Dyn; 2001 Oct; 222(2):218-27. PubMed ID: 11668599
[TBL] [Abstract][Full Text] [Related]
10. Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis.
Thallmair M; Ray J; Stallcup WB; Gage FH
Exp Neurol; 2006 Nov; 202(1):167-78. PubMed ID: 16814771
[TBL] [Abstract][Full Text] [Related]
11. NG2 expression regulates vascular morphology and function in human brain tumours.
Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
[TBL] [Abstract][Full Text] [Related]
12. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan.
de Castro R; Tajrishi R; Claros J; Stallcup WB
Exp Neurol; 2005 Apr; 192(2):299-309. PubMed ID: 15755547
[TBL] [Abstract][Full Text] [Related]
13. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
Tesan T; Gustavsson H; Welén K; Damber JE
BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
[TBL] [Abstract][Full Text] [Related]
15. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of quantitative image analysis of microvascular density in prostate cancer.
Ozerdem U; Wojcik EM; Duan X; Erşahin Ç; Barkan GA
Pathol Int; 2013 May; 63(5):277-82. PubMed ID: 23714256
[TBL] [Abstract][Full Text] [Related]
17. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
Mumenthaler SM; Rozengurt N; Livesay JC; Sabaghian A; Cederbaum SD; Grody WW
Prostate; 2008 Oct; 68(14):1561-9. PubMed ID: 18663728
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.
Kadota K; Huang CL; Liu D; Ueno M; Kushida Y; Haba R; Yokomise H
Eur J Cancer; 2008 May; 44(7):1057-67. PubMed ID: 18396396
[TBL] [Abstract][Full Text] [Related]
19. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.
Young N; Hahn CN; Poh A; Dong C; Wilhelm D; Olsson J; Muscat GE; Parsons P; Gamble JR; Koopman P
J Natl Cancer Inst; 2006 Aug; 98(15):1060-7. PubMed ID: 16882943
[TBL] [Abstract][Full Text] [Related]
20. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
Chen JS; Zhang YJ; Hu SE; Zhang HQ
Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
